These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38936955)

  • 1. Pregnant women and older adults in England and Scotland to be offered RSV vaccination.
    Mahase E
    BMJ; 2024 Jun; 385():q1436. PubMed ID: 38936955
    [No Abstract]   [Full Text] [Related]  

  • 2. Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study.
    Wilcox CR; Calvert A; Metz J; Kilich E; MacLeod R; Beadon K; Heath PT; Khalil A; Finn A; Snape MD; Vandrevala T; Nadarzynski T; Coleman MA; Jones CE
    Pediatr Infect Dis J; 2019 Sep; 38(9):944-951. PubMed ID: 31261362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Giles ML; Buttery J; Davey MA; Wallace E
    Vaccine; 2019 Oct; 37(44):6743-6749. PubMed ID: 31540809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal Outcomes After RSV Vaccination During Pregnancy-Addressing Emerging Concerns.
    Regan AK
    JAMA Netw Open; 2024 Jul; 7(7):e2419229. PubMed ID: 38976273
    [No Abstract]   [Full Text] [Related]  

  • 5. RSV Vaccination Intention Among People Who Are or Plan to Become Pregnant.
    Saper JK; Heffernan M; Simon NE; Davis MM; Macy ML
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38660734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland.
    McCormack S; Thompson C; Nolan M; Imcha M; Dee A; Saunders J; Philip RK
    Immun Inflamm Dis; 2024 Apr; 12(4):e1257. PubMed ID: 38661110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Riddell CA; Bhat N; Bont LJ; Dupont WD; Feikin DR; Fell DB; Gebretsadik T; Hartert TV; Hutcheon JA; Karron RA; Nair H; Reiner RC; Shi T; Sly PD; Stein RT; Wu P; Zar HJ; Ortiz JR;
    Vaccine; 2018 Dec; 36(52):8100-8109. PubMed ID: 30473186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015.
    Hardelid P; Verfuerden M; McMenamin J; Smyth RL; Gilbert R
    Euro Surveill; 2019 Jan; 24(1):. PubMed ID: 30621817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
    Madhi SA; Polack FP; Piedra PA; Munoz FM; Trenholme AA; Simões EAF; Swamy GK; Agrawal S; Ahmed K; August A; Baqui AH; Calvert A; Chen J; Cho I; Cotton MF; Cutland CL; Englund JA; Fix A; Gonik B; Hammitt L; Heath PT; de Jesus JN; Jones CE; Khalil A; Kimberlin DW; Libster R; Llapur CJ; Lucero M; Pérez Marc G; Marshall HS; Masenya MS; Martinón-Torres F; Meece JK; Nolan TM; Osman A; Perrett KP; Plested JS; Richmond PC; Snape MD; Shakib JH; Shinde V; Stoney T; Thomas DN; Tita AT; Varner MW; Vatish M; Vrbicky K; Wen J; Zaman K; Zar HJ; Glenn GM; Fries LF;
    N Engl J Med; 2020 Jul; 383(5):426-439. PubMed ID: 32726529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.
    Kurai D; Mizukami A; Preckler V; Verelst F; Molnar D; Matsuki T; Ho Y; Igarashi A
    Expert Rev Vaccines; 2024; 23(1):303-311. PubMed ID: 38426479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Respiratory Syncytial Virus Adult Vaccination in the United States With a Dynamic Transmission Model.
    Van Effelterre T; Hens N; White LJ; Gravenstein S; Bastian AR; Buyukkaramikli N; Cheng CY; Hartnett J; Krishnarajah G; Weber K; Pastor LH
    Clin Infect Dis; 2023 Aug; 77(3):480-489. PubMed ID: 36949605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.
    Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T
    Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Fleming-Dutra KE; Jones JM; Roper LE; Prill MM; Ortega-Sanchez IR; Moulia DL; Wallace M; Godfrey M; Broder KR; Tepper NK; Brooks O; Sánchez PJ; Kotton CN; Mahon BE; Long SS; McMorrow ML
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(41):1115-1122. PubMed ID: 37824423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priorities for developing respiratory syncytial virus vaccines in different target populations.
    Drysdale SB; Barr RS; Rollier CS; Green CA; Pollard AJ; Sande CJ
    Sci Transl Med; 2020 Mar; 12(535):. PubMed ID: 32188721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus vaccines: an update on those in the immediate pipeline.
    Esposito S; Di Pietro G
    Future Microbiol; 2016 Oct; 11():1479-1490. PubMed ID: 27750448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
    Herring WL; Zhang Y; Shinde V; Stoddard J; Talbird SE; Rosen B
    Vaccine; 2022 Jan; 40(3):483-493. PubMed ID: 34933763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
    Bebia Z; Reyes O; Jeanfreau R; Kantele A; De Leon RG; Sánchez MG; Banooni P; Gardener GJ; Rasero JLB; Pardilla MBE; Langley JM; Di Leo CM; Botelho-Nevers E; Buttery J; Laurichesse H; Madhi SA; García AM; Stanley T; Barjat T; Griffith R; Castrejón-Alba MM; de Heusch M; Dieussaert I; Hercor M; Lese P; Qian H; Tullio AN; Henry O
    J Infect Dis; 2023 Aug; 228(3):299-310. PubMed ID: 36722147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    Green CA; Sande CJ; Scarselli E; Capone S; Vitelli A; Nicosia A; Silva-Reyes L; Thompson AJ; de Lara CM; Taylor KS; Haworth K; Hutchings CL; Cargill T; Angus B; Klenerman P; Pollard AJ
    J Infect; 2019 May; 78(5):382-392. PubMed ID: 30742894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
    August A; Glenn GM; Kpamegan E; Hickman SP; Jani D; Lu H; Thomas DN; Wen J; Piedra PA; Fries LF
    Vaccine; 2017 Jun; 35(30):3749-3759. PubMed ID: 28579233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.